[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4014/jmb.1409.09016

Lactobacillus rhamnosus GG Reverses Insulin Resistance but Does Not Block Its Onset in Diet-Induced Obese Mice

Park, Kun-Young (School of Life Science, Handong Global University)
Kim, Bobae (School of Life Science, Handong Global University)
Hyun, Chang-Kee (School of Life Science, Handong Global University)

Publication Information

Journal of Microbiology and Biotechnology / v.25, no.5, 2015 , pp. 753-757 More about this Journal

Abstract

Recently, Lactobacillus rhamnosus GG (LGG) was shown to exert insulin-sensitizing and adiposity-reducing effects in high-fat (HF) diet-fed mice. In the present study, we observed that the effects were correlated with the extent of dysbiosis induced by HF diet feeding before LGG administration. LGG-treated mice were protected from HF diet-induced adiposity and/or insulin resistance when LGG was treated after, not along with, HF diet feeding. Results indicate that, under HF dietary condition, supplemented LGG reverses insulin resistance, but does not block its onset.

Keywords

Lactobacillus rhamnosus GG; insulin resistance; adiposity; adiponectin; dysbiosis;

Citations & Related Records

Reference

1	Quigley EM. Gut microbiota and the role of probiotics in therapy. 2011. Curr. Opin. Pharmacol. 11: 593-603. DOI ScienceOn
2	Kondo S, Xiao JZ, Satoh T, Odamaki T, Takahashi S, Sugahara H, et al. 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Biosci. Biotechnol. Biochem. 74: 1656-1661. DOI ScienceOn
3	Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, et al. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim. Biophys. Acta 1761: 736-744. DOI ScienceOn
4	Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102: 11070-11075. DOI ScienceOn
5	Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. 1997. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-A^y mice. Endocr. J. 44: 357-365. DOI ScienceOn
6	Olefsky JM, Glass CK. 2010. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72: 219-246. DOI ScienceOn
7	Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A. 2003. Antidiabetic Effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci. Biotechnol. Biochem. 67: 1421-1424. DOI ScienceOn
8	Takemura N, Okubo T, Sonoyama K. 2010. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp. Biol. Med. 235: 849-856. DOI ScienceOn
9	Yadav H, Jain S, Sinha PR. 2007. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 23: 62-68. DOI ScienceOn
10	Andreasen AS, Larsen N, Pedersen-Skovshgaard T, Berg RM, Møller K, Svendsen KD, et al. 2010. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 104: 1831-1838. DOI ScienceOn
11	Aronsson L, Huang Y, Parini P, Korach-Andre M, Hakansson J, Gustafsson JA, et al. 2010. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One 5: e13087. DOI
12	Cani PD, Delzenne NM. 2009. Interplay between obesity and associated metabolic disorders: new insights into the gut. Curr. Opin. Pharmacol. 9: 737-743. DOI ScienceOn
13	Cao H. 2014. Adipocytokines in obesity and metabolic disease. J. Endocrinol. 220: T47-59. DOI ScienceOn
14	Clemente JC, Ursell LK, Parfrey LW, Knight R. 2012. The impact of the gut microbiota on human health: an integrative view. Cell 148: 1258-1270. DOI ScienceOn
15	Honda K, Moto M, Uchida N, He F, Hashizume N. 2012. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J. Clin. Biochem. Nutr. 51: 96-101. DOI ScienceOn
16	Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846. DOI ScienceOn
17	Kim SW, Park KY, Kim B, Kim E, Hyun CK. 2013. Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem. Biophys. Res. Commun. 431: 258-263. DOI ScienceOn
18	Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. 2011. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7: 639-646. DOI ScienceOn

Reference

5	(2015) Beneficial microbes Supplementation with <I>Lactobacillus rhamnosus</I> SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne / 7 (5) , 625
None	(2016) Scientific reports Isolated exopolysaccharides from <I>Lactobacillus rhamnosus</I> GG alleviated adipogenesis mediated by TLR2 in mice / 6 (None) , 36083
None	(2018) Contemporary clinical trials communications A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults / 12 (None) , 192
3	(2015) Heliyon Use of coconut water ( <I>Cocus nucifera L</I> ) for the development of a symbiotic functional drink / 6 (3) , e03653
5	(2015) Food & function Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice / 11 (5) , 4773
11	(2015) Food & function Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice / 11 (11) , 9947
11	(2015) Food & function Enzymatically synthesized α-galactooligosaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with the modulation of gut microbiota / 12 (11) , 4960